Many physicians weighed in on the “Biggest cardiology stories of 2012” at theheart.org, and the following news was mentioned as the most important for interventional cardiology:
- Results of the FREEDOM trial on treatment of diabetic patients with multivessel disease
- Results of the FAME II trial on the importance of ischemic documentation on outcomes after PCI
- The IABP SHOCK II trial insights on how to treat cardiogenic-shock patients with PCI and the role of balloon-pump support in those cases
- Transcatheter aortic-valve replacement and the evolution of novel devices and iterations to improve acute and late outcomes
Looking forward to 2013, the initiation of the MitraClip was mentioned as something that could change percutaneous mitral valve repair. Also, there could be changes to the transcatheter aortic-valve technique based on results of the CoreValve trial and results from patients treated with the Edwards device (Read the December 2012 article from Vascular Disease Management for original research on vascular complications using the Edwards SAPIEN device).
Also mentioned as a hot topic for 2013 were the PARTNER II results using the next-generation SAPIEN XT valve and lower-profile NovoFlex delivery system from Edwards Lifesciences.
What news was most important to your practice this year? What do you most look forward to in 2013?